Transfusion Medicine and Hemotherapy

期刊全称Transfusion Medicine and Hemotherapy
期刊缩写TRANSFUS MED HEMOTH
涉及主题医学生物重症监护医学内科学免疫学化学遗传学
期刊介绍

This journal is devoted to all areas of transfusion medicine. These include the quality and security of blood products, therapy with blood components and plasma derivatives, transfusion-related questions in transplantation, stem cell manipulation, therapeutic and diagnostic problems of homeostasis, immuno-hematological investigations, and legal aspects of the production of blood products as well as hemotherapy. Both comprehensive reviews and primary publications that detail the newest work in transfusion medicine and hemotherapy promote the international exchange of knowledge within these disciplines. Consistent with this goal, continuing clinical education is also specifically addressed.

期刊ISSNprint: 1660-3796
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
1.92.24.043.7471.93732.1521.76
历年发表/被引量
年份20252024202320222021202020192018201720162015201420132012
发表量15598372676094777975818310396
被引量787208221702326223720641775146412781200938882773544
h-Index33
自引率5.30%
涉及的研究领域医学-免疫学
中科院2025年分区 ?
大类小类TOP期刊综述期刊
4区4区 血液学
4区免疫学
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
HEMATOLOGYSCIEQ362/98
IMMUNOLOGYSCIEQ4147/183

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
HEMATOLOGYSCIEQ370/99
IMMUNOLOGYSCIEQ4148/183
期刊主页http://www.karger.com/Journal/Home/224170https://www.karger.com/tmh
投稿网址http://www.karger.com/Journal/Guidelines/224170
出版商S. Karger AG
出版国家(地区)SWITZERLAND
出版语言English
出版周期Bimonthly
每年出版文章数51
Gold OA文章占比92.62%
原创研究文献占比
(排除综述)
63.04%
SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1660-3796%5BISSN%5D
平均审稿周期较慢,6-12周
平均录用比例较易
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈